Last Updated on October 2, 2023 at 9:26 am
A reader asks, “Dear sir, thank you for the helpful insights on Life Insurance Claim Settlement Ratio for FY 2020-21. Can we get similar data for health insurers?”
Life insurance claims are binary. Either insurer pays in full (one) or not (zero). So you can define a claim settlement ratio as the number of claims paid divided by the total number of claims. Also see: Claim settlement ratio is not a probability of life insurance claim acceptance!
Such a definition is impossible in health insurance because claims are not binary. A claim can be settled to any extent from 0 to 100%.
Note: None of the insurer names mentioned below or associated metrics is insurance purchase recommendations. Use the resources mentioned at the end of the article to arrive at a decision.
Join over 32,000 readers and get free money management solutions delivered to your inbox! Subscribe to get posts via email! 🔥Enjoy massive discounts on our robo-advisory tool & courses! 🔥
It is a pity that bloggers and content creators in search of “some ratio” related to health insurance use the “claim incurred ratio” as a measure to represent the “claim playability” of a health insurer. This is rubbish.
The incurred claim ratio (ICR) is defined as net incurred claims divided by net earned premium (net of all operating expenses, commissions etc.). This should neither be too low nor too high but how low is low and high is high are quite arbitrary.
If the ICR is low, net incurred claims << net earned premium for a particular financial year. This means the profit margin for the insurer is high. So an investor (in the insurance company) would prefer this.
If the ICR is high, the net incurred claims will reduce the profit margin. So an investor will not want this!
The ICR is a crude measure of the insurance company’s financial strength. It has nothing to do with the probability of an insurance company payout. A young private insurer will see violent fluctuations in its ICR from one FY to another. This is because the number of claims received and the amount paid will vary quite a bit—more on this in a separate post.
Even for established players, ICR can fluctuate wildly. Take Star Health, for instance. They have been around since 2006. Their ICR in 2019-20 was 65.91%, and in 2020-21 it increased to 94.44%. What does this tell you other than the fact their profitability was lower in 2020-21?
If I was thinking about investing in Star Health, I may think twice or dig deeper. If I am an existing customer or a potential customer, do these numbers help in any way. No, they do not.
These are the ICRs of standalone health insurers reported by IRDA in its 2020-21 report (page 171).
| Name | 2019-20 | 2020-21 |
| Aditya Birla Health Insurance | 49.08 | 49.99 |
| Care Health | 59.13 | 55.15 |
| HDFC ERGO | 73.69 | NA* |
| ManipalCigna Health Insurance | 61.64 | 61.13 |
| Max Bupa Insurance | 53.51 | 56.09 |
| Reliance Health Insurance | 62.17 | 45.68 |
| Star Health and Allied Insurance | 65.91 | 94.44 |
* HDFC ERGO Health merged with HDFC ERGO General Insurance.
Some people claim that ICR should be between 70% to 90%. So does this mean none of these insurers is “good”? Again this is rubbish. The ICR is a profitability measure and not a claim settlement-ability measure. Health insurance purchase is complicated enough. Let us not make it worse by adding worthless “metrics”.
Even if the ICR looks stable today (across two FY) and within these precious limits, they are unlikely to stay that way after you buy!
As we had seen in the case of life insurance, market share makes a difference. The PSU insurer account for 45% of all health insurance premium collected (gross – before fees and expenses).
The standalone health insurance gross premium as a percentage of the PSU total is tabulated below. This data is also available for general insurers (towards health insurance alone), but we shall consider it in another article.
| Name | 2019-20 | 2020-21 |
| Aditya Birla Health Insurance | 3.4% | 4.5% |
| Care Health | 9.2% | 8.9% |
| HDFC ERGO | 9.7% | |
| ManipalCigna Health Insurance | 2.2% | 2.6% |
| Max Bupa Insurance | 4.8% | 6.1% |
| Reliance Health Insurance | 0.0% | 0.0% |
| Star Health and Allied Insurance | 26.4% | 32.5% |
Only Star Health has a reasonable market share when compared to PSU insurers.
Can we determine how many claims health insurers reject each year?
We can only answer this question for standalone health insurers. IRDA does not provide break up details for the total claims processed by general insurers. For general insurers (including PSUs), we do not know how many of the claims were health insurance claims.
Before we look at the data, we must make an important distinction.
Claim repudiation is the refusal to honour a claim because the insurer (in their opinion) has no liability over the circumstances mentioned in the claim. The only way forward is to apply to the grievance cell of the insurer for reevaluation or to the ombudsman or the consumer court.
Claim rejection is the refusal to honour a claim because the insurer has found the application inaccurate or incomplete. Typically a resubmission is allowed.
When we colloquially refer to “claim rejection”, we only refer to repudiation.
| Name | Claims repudiated by Total claims outstanding in FY 2020-21 |
| Aditya Birla Health Insurance | 10.1% |
| Care Health | 6.9% |
| HDFC ERGO | |
| ManipalCigna Health Insurance | 9.6% |
| Max Bupa Insurance | 9.1% |
| Reliance Health Insurance | 41.5% |
| Star Health and Allied Insurance | 15.0% |
Please note that Total claims outstanding are the sum of claims not resolved at the start of FY 2020-21 and the claims received that FY. This is not (1- claim settlement ratio) because claim acceptance does not mean 100% payout!. Even if the insurer pays 1% of the claimed amount and repudiates 99%, it will be counted as a processed claim!
Settling 85% of the claims (in full or in part) implies that Star Health lost almost all the premium collected in FY 2020-21 (ICR = 94.4%). This indicates how fragile the health insurance business is.
According to a reputed insurance intermediary, private insurers are extremely conscious about building a healthy insured pool. This is why they reject those with pre-existing diseases or completely exclude these conditions from the liability! This is why they offer “benefits” for staying fit. They want to do their best to reduce claim applications!
The problem is, even if the insurer is careful to build a healthy insured pool, a greedy intermediary can put a spoke in their plans by “encouraging” buyers to hide relevant information.
PSUs can afford to have a health ICR of 100% year after year (at least they go public), but private insurers cannot.
Was Start Health forced to reject more claims than other standalone insurers because they received more claims?
| Name | Total claims outstanding in FY 2020-21 |
| Star Health and Allied Insurance | 1105347 |
| Care Health | 439186 |
| ManipalCigna Health Insurance | 248404 |
| Max Bupa Insurance | 141388 |
| Aditya Birla Health Insurance | 115120 |
| Reliance Health Insurance | 217 |
On average, it would be reasonable to expect that standalone health insurers will repudiate 10% of the claims received. Whether our claim is part of that 10% or not is impossible to tell!
In comparison, the PSUs repudiate less than 5% of all claims (health and general insurance) received (the average is 2% for FY 2020-21). Health accounts for only 35% of gross premiums collected in FY 2019-20 and 40% in FY 2020-21.
Those who hold health insurance from private players must appreciate that they will roll out the red carpet at the time of sales (since their market share is low). The buyer should not expect the same treatment at the time of claim. They have their ICRs to worry about!
Resources to buy health insurance.
- New features introduced in United India Insurance Family Medicare Policy
- This free ebook on Health Insurance will help you choose a policy with ease!
- Download a Health Insurance Policy Comparison Spreadsheet
- How to select a health insurance policy in 2020: A Webinar
🔥Enjoy massive discounts on our courses, robo-advisory tool and exclusive investor circle! 🔥& join our community of 5000+ users!
Use our Robo-advisory Tool for a start-to-finish financial plan! ⇐ More than 1,000 investors and advisors use this!
New Tool! => Track your mutual funds and stock investments with this Google Sheet!
We also publish monthly equity mutual funds, debt and hybrid mutual funds, index funds and ETF screeners and momentum, low-volatility stock screeners.
- Do you have a comment about the above article? Reach out to us on Twitter: @freefincal or @pattufreefincal
- Have a question? Subscribe to our newsletter using the form below.
- Hit 'reply' to any email from us! We do not offer personalized investment advice. We can write a detailed article without mentioning your name if you have a generic question.
Join over 32,000 readers and get free money management solutions delivered to your inbox! Subscribe to get posts via email!
About The Author
Dr M. Pattabiraman(PhD) is the founder, managing editor and primary author of freefincal. He is an associate professor at the Indian Institute of Technology, Madras. He has over ten years of experience publishing news analysis, research and financial product development. Connect with him via Twitter(X), Linkedin, or YouTube. Pattabiraman has co-authored three print books: (1) You can be rich too with goal-based investing (CNBC TV18) for DIY investors. (2) Gamechanger for young earners. (3) Chinchu Gets a Superpower! for kids. He has also written seven other free e-books on various money management topics. He is a patron and co-founder of “Fee-only India,” an organisation promoting unbiased, commission-free investment advice.Our flagship course! Learn to manage your portfolio like a pro to achieve your goals regardless of market conditions! ⇐ More than 3,000 investors and advisors are part of our exclusive community! Get clarity on how to plan for your goals and achieve the necessary corpus no matter the market condition is!! Watch the first lecture for free! One-time payment! No recurring fees! Life-long access to videos! Reduce fear, uncertainty and doubt while investing! Learn how to plan for your goals before and after retirement with confidence.
Our new course! Increase your income by getting people to pay for your skills! ⇐ More than 700 salaried employees, entrepreneurs and financial advisors are part of our exclusive community! Learn how to get people to pay for your skills! Whether you are a professional or small business owner who wants more clients via online visibility or a salaried person wanting a side income or passive income, we will show you how to achieve this by showcasing your skills and building a community that trusts and pays you! (watch 1st lecture for free). One-time payment! No recurring fees! Life-long access to videos!
Our new book for kids: “Chinchu Gets a Superpower!” is now available!
Must-read book even for adults! This is something that every parent should teach their kids right from their young age. The importance of money management and decision making based on their wants and needs. Very nicely written in simple terms. - Arun.Buy the book: Chinchu gets a superpower for your child!
How to profit from content writing: Our new ebook is for those interested in getting side income via content writing. It is available at a 50% discount for Rs. 500 only!
Do you want to check if the market is overvalued or undervalued? Use our market valuation tool (it will work with any index!), or get the Tactical Buy/Sell timing tool!
We publish monthly mutual fund screeners and momentum, low-volatility stock screeners.
About freefincal & its content policy. Freefincal is a News Media Organization dedicated to providing original analysis, reports, reviews and insights on mutual funds, stocks, investing, retirement and personal finance developments. We do so without conflict of interest and bias. Follow us on Google News. Freefincal serves more than three million readers a year (5 million page views) with articles based only on factual information and detailed analysis by its authors. All statements made will be verified with credible and knowledgeable sources before publication. Freefincal does not publish paid articles, promotions, PR, satire or opinions without data. All opinions will be inferences backed by verifiable, reproducible evidence/data. Contact information: letters {at} freefincal {dot} com (sponsored posts or paid collaborations will not be entertained)
Connect with us on social media
- Twitter @freefincal
- Subscribe to our YouTube Videos
- Posts feed via Feedburner.
Our publications
You Can Be Rich Too with Goal-Based Investing
Published by CNBC TV18, this book is meant to help you ask the right questions and seek the correct answers, and since it comes with nine online calculators, you can also create custom solutions for your lifestyle! Get it now.Gamechanger: Forget Startups, Join Corporate & Still Live the Rich Life You Want
This book is meant for young earners to get their basics right from day one! It will also help you travel to exotic places at a low cost! Get it or gift it to a young earner.Your Ultimate Guide to Travel
This is an in-depth dive into vacation planning, finding cheap flights, budget accommodation, what to do when travelling, and how travelling slowly is better financially and psychologically, with links to the web pages and hand-holding at every step. Get the pdf for Rs 300 (instant download)